- Home
- ESPR vs RFI Comparison
ESPR vs RFI Comparison
Compare ESPR & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- RFI
- Stock Information
- Founded
- ESPR 2008
- RFI 1992
- Country
- ESPR United States
- RFI United States
- Employees
- ESPR N/A
- RFI N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- RFI Investment Managers
- Sector
- ESPR Health Care
- RFI Finance
- Exchange
- ESPR Nasdaq
- RFI Nasdaq
- Market Cap
- ESPR 305.0M
- RFI 321.0M
- IPO Year
- ESPR 2013
- RFI N/A
- Fundamental
- Price
- ESPR $1.69
- RFI $11.95
- Analyst Decision
- ESPR Buy
- RFI
- Analyst Count
- ESPR 7
- RFI 0
- Target Price
- ESPR $6.36
- RFI N/A
- AVG Volume (30 Days)
- ESPR 4.2M
- RFI 69.8K
- Earning Date
- ESPR 03-04-2025
- RFI 01-01-0001
- Dividend Yield
- ESPR N/A
- RFI 8.25%
- EPS Growth
- ESPR N/A
- RFI N/A
- EPS
- ESPR N/A
- RFI N/A
- Revenue
- ESPR $332,314,000.00
- RFI N/A
- Revenue This Year
- ESPR $5.51
- RFI N/A
- Revenue Next Year
- ESPR $1.42
- RFI N/A
- P/E Ratio
- ESPR N/A
- RFI N/A
- Revenue Growth
- ESPR 185.66
- RFI N/A
- 52 Week Low
- ESPR $1.47
- RFI $9.62
- 52 Week High
- ESPR $3.94
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- ESPR 49.78
- RFI 47.01
- Support Level
- ESPR $1.47
- RFI $11.61
- Resistance Level
- ESPR $1.61
- RFI $12.04
- Average True Range (ATR)
- ESPR 0.12
- RFI 0.18
- MACD
- ESPR 0.02
- RFI -0.02
- Stochastic Oscillator
- ESPR 56.41
- RFI 43.08
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.